Pharmaceutical

FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine 

The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.

Nov 13, 2024 - 06:00
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine 
The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.
Read the original article

Tags:

Previous Article

Pfizer considers divestiture of hospital drugs business

Next Article

NHS launches “game-changer” and lifesaving anti-smoking pill

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: How drug pricing reforms are affecting Bayer’s investments

STAT+: How drug pricing reforms are affecting Bayer’s i...

Jun 20, 2023

STAT+: Relay’s breast cancer drug proves tolerable, but market is unimpressed

STAT+: Relay’s breast cancer drug proves tolerable, but...

Apr 19, 2023

FDA accepts Merck’s Keytruda plus Padcev sBLA to treat urothelial cancer

FDA accepts Merck’s Keytruda plus Padcev sBLA to treat ...

Dec 2, 2023